Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.
about
Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling studyEstimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza virusesCompetitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in FerretsCharacterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in JapanEpistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza virusesEvolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant RecipientModelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.VIRAPOPS2 supports the influenza virus reassortmentsCharacterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.Rapid and simple detection of Tamiflu-resistant influenza virus: Development of oseltamivir derivative-based lateral flow biosensor for point-of-care (POC) diagnostics
P2860
Q28537982-3FBF8C55-4B3C-40D4-AB6D-98F01D82B322Q28541953-34C6ECB5-7651-444E-972B-35BB85483D75Q28553195-28358C29-37C3-49F0-8761-EBB7D3B3C221Q30371865-53643994-96BF-46AF-9F3C-78E3316E2184Q34339407-398F8552-EE48-4EAA-B8A9-ECDA9F5A6BCFQ34597005-9143B629-6693-4644-AAEA-EC3A57D75596Q35794372-31C7BA39-82F4-46AE-A7DD-5BB0538D51A8Q36250190-D41CD535-D084-4BC7-97FE-65191D252446Q40138039-80536DC2-40C8-474A-93FC-6D3AAD280320Q40639592-13B093DB-7B0A-4E21-9B5C-E0D3969FA329Q42167160-60B2105E-8B6B-45D1-B0B3-719A74F1B9A3Q42199847-0C9301F1-AB5A-4CC6-94EE-D3206E31BFA4Q55426854-508741AB-50E7-4F19-863A-F1A705AEA25DQ58695383-59E2E690-B728-47B1-AC14-E9B357C12ACC
P2860
Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Impact of potential permissive ...... vitro, in mice and in ferrets.
@en
Impact of potential permissive ...... vitro, in mice and in ferrets.
@nl
type
label
Impact of potential permissive ...... vitro, in mice and in ferrets.
@en
Impact of potential permissive ...... vitro, in mice and in ferrets.
@nl
prefLabel
Impact of potential permissive ...... vitro, in mice and in ferrets.
@en
Impact of potential permissive ...... vitro, in mice and in ferrets.
@nl
P2093
P2860
P356
P1433
P1476
Impact of potential permissive ...... vitro, in mice and in ferrets
@en
P2093
Chantal Rhéaume
Guy Boivin
Xavier Bouhy
Yacine Abed
P2860
P304
P356
10.1128/JVI.02681-13
P407
P577
2013-11-20T00:00:00Z